The Board of Directors of Biofil Chemicals & Pharmaceuticals Limited, at its meeting held today have approved the unaudited Standalone financial results of the company for the period ended September 30, 2021.
For the quarter ended September 30, 2021(Q2 FY2022), the company's total income was ₹ 13.7690 crore, against ₹16.1645 crore in the corresponding quarter of the previous year (YoY) and ₹5.3894 crore in previous quarter (QoQ).
For the quarter ended September 30, 2021(Q2 FY2022), the company's net profit / (loss) was ₹0.2126 crore, against ₹0.9271 crore in the corresponding quarter of the previous year (YoY) and ₹0.1739 crore in previous quarter (QoQ).
For the quarter ended September 30, 2021(Q2 FY2022), the company's Earnings Per Share (EPS) was ₹0.13, against ₹0.57 in the corresponding quarter of the previous year (YoY) and ₹0.11 in previous quarter (QoQ).
Total Income | ₹ 13.7690 crs | ₹5.3894 crs | 155.48% | ₹16.1645 crs | -14.82% |
Net Profit | ₹0.2126 crs | ₹0.1739 crs | 22.25% | ₹0.9271 crs | -77.07 % |
EPS | ₹0.13 | ₹0.11 | 18.18% | ₹0.57 | -77.19% |
For the 6 Months period ended September 30, 2021(Half Year Ended FY 2022), the company's total income was ₹19.1583 crore, against ₹19.1018 crore in the previous year (YoY) (Half Year Ended FY 2021).
The net profit / (loss) was at ₹0.3865 crore for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), compared to ₹1.1437 crore in the previous year (YoY) (Half Year Ended FY 2021).
The Earnings Per Share stood at ₹0.24 for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), against ₹0.70 in the previous year (YoY) (Half Year Ended FY 2021).
Total Income | ₹19.1583 crs | ₹19.1018 crs | 0.30% |
Net Profit | ₹0.3865 crs | ₹1.1437 crs | -66.21% |
EPS | ₹0.24 | ₹0.70 | -65.71% |
Shares of Biofil Chemicals & Pharmaceuticals Limited was last trading in BSE at Rs. 60.25 as compared to the previous close of Rs. 60.85. The total number of shares traded during the day was 1484 in over 44 trades.
The stock hit an intraday high of Rs. 61.80 and intraday low of 60.10. The net turnover during the day was Rs. 89671.00.
Source : Equity Bulls
Keywords
BiofilChemicalsandPharmaceuticals
Q2FY22
H1FY22
ResultUpdate